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Abstract.  Expression of the two isoforms of cardiac 
myosin heavy chain (MHC), MHCot and MHC/3,  in 
mammals is regulated postnatally by a variety of stim- 
uli, including serum hormone levels. Less is known 
about the factors that regulate myosin gene expression 
in rapidly growing cardiac muscle in embryos. Using 
isoform-specific 35S-labeled cRNA probes correspond- 
ing to the two MHC genes and the two myosin alkali 
light chain (MLC) genes expressed in cardiac muscle, 
we have investigated the temporal and spatial  pattern 
of expression of these different genes in the developing 
mouse heart by in situ hybridization. Between 7.5 and 
8 d post coitum (p.c.), the newly formed cardiac tube 
begins to express MHCct, MHC/3,  MLC1  atrial 
(MLC1A), and MLC1  ventricular (MLC1V)  gene tran- 
scripts at high levels throughout the myocardium. As a 
distinct ventricular chamber forms between 8 and 9 d 
p.c., MHC/3 mRNAs begin to be restricted to ventric- 
ular  myocytes. This process is complete by 10.5  d p.c. 
During this  time, MHCa  mRNA  levels  decrease in 
ventricular  muscle cells  but continue to be expressed 
at high levels  in atrial  muscle cells.  MHCot transcripts 
continue to decrease in ventricular  myocytes until  16 d 
p.c.,  when they  are detectable  at low levels,  but then 
increase,  and finally  replace  MHC/3 mRNAs  in ven- 
tricular  muscle by 7 d after  birth.  Like MHC/~, 
MLC1V transcripts become restricted to ventricular 
myocytes, but at a  slower rate. MLCIV mRNAs con- 
tinuc to be detected at low levels in atrial cells until 
15.5 d p.c.  MLC1A mRNA levels gradually decrease 
but are still detectable in ventricular cells until a few 
days after birth.  This dynamic pattern of changes in 
the myosin phenotypc in the prenatal mouse heart sug- 
gests that there are different regulatory mechanisms 
for cell-specific expression of myosin isoforms during 
cardiac development. 
C 
ARDIAC muscle is  known to contain  at  least  two dif- 
ferent  isoforms  of  myosin heavy chain  (MHC)  t  and 
two  myosin alkali  light  chains  (MLC), which  are  en- 
coded  by  distinct  genes  (Mahdavi et  al.,  1982;  Barton  et  al., 
1985, 1988).  The genes encoding the two MHC  proteins, 
called  MHCa  and  MHCB  (Hob et  al.,  1978),  are  organized 
in  tandem (Mahdavi et  al.,  1984)  and are developmentally 
and hormonally regulated (Lomprd  et al.,  1984). These 
genes are also  regulated differentially in  response  to  cardiac 
hypertrophy  due to hemodynamic overload  (Izumo et al., 
1987;  reviewed  in  Nadal-Ginard and Mahdavi, 1989).  The 
MLC genes,  MLCIA and MLCIV, are  coexpressed  and  de- 
velopmentally  regulated  in  cardiac  and  skeletal  muscle (Bar- 
ton and Buckingham, 1985;  Lyons ct al.,  1990b). These 
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MLC  genes  are  regulated  differentially  during  cardiac 
hypertrophy  in humans (Cummins, 1982; Kurabayashi et al., 
1988) but not in rodents (Rovner et al.,  1990), and do not 
appear to be hormonally regulated (Schwartz et al., 1982). 
In the adult rodent heart, MLC1V is present in the ventricles 
and MLCIA in the atria, while MHCct is the major isoform 
in both compartments. 
Most of the reports on myosin expression  in embryonic 
cardiac muscle have involved antibody studies of the chick 
heart. Zhang et al. (1986) and Sweeney et al. (1987) report 
that at Hamburger-Hamilton stage 10 (1.25 d in ovo), only 
the adult ventricular MHC  is  detectable.  Approximately 
1 d later, stage 12-15, atrial MHC starts to be expressed in 
embryonic chick hearts. There is one report of an antibody 
study of MHCs in the embryonic rat heart. De Groot et al. 
(1989) show that MHCo~ and MHC/~ are coexpressed in 
tubular rat  hearts  (embryonic day  10-11). Biochemical 
studies  of developing mammalian hearts have shown that 
MHC/3 is  the predominant MHC  in late fetal ventricles 
(Lompr6 et al., 1981; Schwartz et al., 1982). However,  there 
are variations in the developmental patterns of MHC protein 
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(Lompr6 et al.,  1981).  Variations in MHC proteins in atria 
and ventricles appear to be related to animal size (Syrovy, 
1985). There are a few studies of the MLC protein content 
of fetal cardiac muscle; these have shown that MLC1A is ex- 
pressed in fetal ventricles (Whalen and Sell, 1980; Cummins 
and Lambert,  1986). 
We are interested in the regulation of myosin gene expres- 
sion  in  the  developing  manunalian  heart,  particularly  at 
early stages in the embryo. To characterize the normal pat- 
tern of expression of MHC and MLC genes, we have used 
isoform-specific cRNA probes to MHCc~, MHC~, MLC1A, 
and MLC1V mRNAs for in situ hybridization of the mouse 
embryonic and fetal heart. We show that, after an initial high 
level of coexpression in the myocardium of the cardiac tube 
at 8 d post coitum (p.c.), each of  these transcript  s has a differ- 
ent pattern of accumulation suggesting that each is regulated 
in a different cell-specific and stage-specific manner in de- 
veloping atrial and ventricular myocytes. 
Materials and Methods 
Preparation and Prehybridization of Tissue Sections 
The protocol that was used to fix and embed C3H and BALB/c mouse em- 
bryos, fetuses, and postnatal hearts is described in detail in Sassoon et al. 
(1988). Ages and numbers of embryos and fetuses examined are listed in 
Table I. Briefly, embryos were fixed in 4% paraformaldehyde in PBS, de- 
hydrated,  and intiltrated with paraffin.  5-7-/~m-thick serial sections were 
mounted on subbed slides (Gall and Pardue,  1971).  One to three sections 
were mounted per slide, deparaflinized in xylene, and rehydrated. The sec- 
tions were digested with proteinas¢ K, postflxed, treated with triethanola- 
mine/acetic anhydride,  washed,  and dehydrated. 
Probe Preparation 
To distinguish between transcripts within the myosin multigerm family, it is 
necessary to use probes derived from the 3' or 5' noncoding untranslated 
regions (UTR) of the mRNAs. Appropriate restriction fragments or oligo- 
nucleotides were subcloned into the vector, Bluescribe+ (Stratagene Clon- 
ing Systems, La Jolla, CA) and grown in E. coli TGI. The following probes 
were used. (/) 3' UTR of mouse MLC1Atrial mRNA (Barton et al.,  1988) 
5'TTAATGAAAC  TC  CAAGC~TCTTTATTTC  CA~GGTT- 
Figure 1. Myosin gene expression in the atrioventricular junction of the newly formed cardiac tube. (a) Phase-contrast micrograph of a 
parasagittal section of an 8-d p.c. mouse embryo with four somites. (b) Dark-field micrograph of the same section as in a hybridized to 
the MLC1A  probe. Serial slides were hybridized to the probes for (c) MHCc~, (d) MLC1V, and (e) MHC/5. (The actual sequence in which 
the sections were cut is MHCc~, MLC1A, MLCIV, MHC/3.) S, somites; H, headfold; CT, cardiac tube. Bar, 300 ~,m. 
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AGCCGCTG~TCTCTIC~TTTCTCACGC~GC~CAAGCY.  These 
sequence data are available from EMBL/GenBank/DDJB under accession 
numbers M20773,  M19435, and J03932.  (2) 3' UTR of the mouse MLC1- 
Ventricular mRNA (Lyons et al.,  1990b) 5'GGAGTCCGAACCACTCC- 
TTC CCGAAGCTCCAGACATGGTGAGCATCCTGG~GATG- 
C~CTGCCC~CTGA3'.  These sequence data are avail- 
able from EMBL/GenBank/DDJB under accession number X53489. (3) 3' 
UTR  of rat MHCVentricular (MI-IC~)  mRNA  (Mahdavi et al.,  1982) 
5'GGTC  TC  AGCJGC  TICACA~TICC'IWAFJGG~TAGCACAT- 
GATCTACTCTTCA~CTI"G3'.  These sequence data are available 
from EMBL/GenBank/DDJB under accession number K01463. (4) 3' end 
of  the  mouse  MHCAtrial  (MHC~x)  mRNA  (Weydert  et  el.,  1985) 
5'CGAAC  GTTTATGTTTATTG~~CACAGCGAGGGTCTG- 
CTGGAGAGGTTAT ICCTCGTC3'.  These sequence data are available fi'om 
Figure 2.  MHC/3 is restricted to ventricular cells at an early stage 
in cardiac muscle development. (a) Phase-contrast micrograph of 
a parasagittal  section through  a 9.5-d p.c. embryo with 21-24 so- 
mites. (b) Dark-field micrograph of the same section as in a hybrid- 
ized to the MLC1V  probe.  (c) A parallel section hybridized with 
the MHC/~ probe.  (d) A parallel section hybridized to the MHCc~ 
probe.  VA, ventriculoarterial  portion; A,  atrium; H,  hyoid arch. 
Bar, 300 #m. 
Figure 3. Myosin gene transcripts are detected in the developing sinuatrial transition (a-f, arrowheads). (a) Phase-contrast and (b) dark-field 
micrographs ofa parasagittal section through a 10.5-dp.c. embryonic heart hybridized with the MLC1A probe. Serial slides were hybridized 
to the probes for (c) MHCc~, (d) MHC/5, and (e) MLC1V. MHC05 transcripts continue to be expressed in the right side of the sinuatrial 
transition (d, right arrowhead).  (f) A parallel section, 50 gm from that in e, was hybridized with the MLC1A prQbe, showing the sinuatrial 
transition (arrowhead) and the ventriculoarterial canal (VA; which is indicated by arrows in c and e). (There is a small fold in the section 
over the atrium in c.)  Z  trabeculae; A,  atrium;  V, ventricle. Bar,  300 ~m. 
Lyons et al. Myosin C-ene Expression in Mouse Cardiac Muscle  2429 Figure 4. Between 10.5 and 15.5 d p.c., MLC1V transcripts gradually become restricted to ventricular cells. Parallel parasagittal sections 
through an 11.5-d p.c. mouse heart hybridized with (a) the MLCIV probe and with the MHCc~ probe (b) phase micrograph and (c) corre- 
sponding dark-field micrograph. The boundary for restriction of atrial and ventricular transcripts is the atrioventricular transition (a and 
c, arrowheads). ECC, endocardial cushions; OR, outflow ridges;/VS, interventricular septum,  V~, venous valves. Bar, 400 #m. 
EMBL/GenBank/DDJB under accession  numbe~ M12291 and X5M90. The 
cRNA transcripts were synthesized according to manufacturer's conditions 
(Stratagene Cloning Systems) and labeled with 35S-UTP (>1,000 Ci/mmol; 
Amersham International, Amersham, UK). cRNA transcripts larger than 
100 nucleotides were subjected to alkali hydrolysis to give a mean size of 
70 bases for efficient hybridization. 
Hybridization and Washing Procedures 
Sections were hybridized overnight at 52°C in 50% deionized formamide, 
0.3 M NaCI, 20 mM Tris-HCl, pH 7.4, 5 mM EDTA, 10 mM NaPO4, 
10%  dextran  sulfate,  Ix  Denhardt's,  50  /~g/ml total  yeast  RNA,  and 
50--75,000 cpm//~l 35S-labeled cRNA probe. The tissue was subjected to 
stringent washing at 65°C in 50% formamide, 2×SSC,  10 mM DTT and 
washed in PBS before treatment with 20/~g/ml RNAse A at 37°C for 30 
min. Following washes in 2xSSC and 0.1×SSC for 15 min at 37°C, the 
slides were dehydrated and dipped in Kodak NTB-2 nuclear track emulsion 
and exposed for 1 wk in light fight boxes with dessicant at 4°C. Photo- 
graphic development was carried out in Kodak D-19. Slides were analyzed 
using both light- and dark-field optics of a Zeiss Axiophot microscope. 
Figure 5. Atrial-specific transcripts disappear from the ventricle in a gradient of expression. (a-d) Dark-field micrographs of parasagittal 
sections through a 15.5-d p.c. mouse heart. (e-h) Dark-field micrographs of parasagittal sections through a 16.5-d p.c. mouse heart. Serial 
slides at the two different stages were hybridized with the MHCc~ probe (d and h), the MLCIA probe (a and e), the MHCI5 probe (c and 
g),  and the MLCIV probe (b and f). R, ribs; pulmonary blood vessel (arrow). Bars: (a-d) 600 ~tm; (e-h) 750 #m. 
The Journal of Cell Biology, Volume 111, 1990  2430 Figure 6. At 15 d p.c., MHCc~ and MLC1A transcripts beginto be detectable around some blood vessels outside the heart. (a) Bright-field 
micrograph of a 15.5-d p.c. mouse thorax showing the inferior vena cava (/VC), which expresses MLCIA transcripts (b, arrows). At 17.5 d 
p.c. (c) MLC1A transcripts are detected in a sleeve of atrial muscle that surrounds some pulmonary vessels (arrowheads). Parallel sections 
of neonatal mouse hearts were hybridized with the probes for (d) MLC1A, (e) MHCc~, and (f) MHC/3. Pulmonary vessels (d and e, arrow- 
heads); LI, liver; A, atrium; L, lung; D, diaphragm. Bars: (a and b) 300/~m;  (c) 800/~m; (d-f) 800 tzm. 
Results 
By 8 d p.c. in the mouse embryo, a tubular heart has formed 
and the first myocardial contractions occur (Rugh, 1990; Siss- 
man,  1970).  At first, the tubular heart is S-shaped.  Serial 
sections from the midsagittal section in Fig. 1 c in the order 
Fig.  1, c, b, d, and e show the lower half of the S-curve, or 
the atrioventricular junction (Pexeider et al.,  1989), of the 
developing heart. At this stage, each of the four myosin tran- 
scripts that we studied is expressed at a high level in all of 
the myocardial cells (Fig.  1). This observation suggests that 
all of the myosin genes in the heart are upregulated initially 
in a coordinated fashion. These results are consistent with 
antibody studies of the myofibrillar proteins in the develop- 
ing rodent heart, which have shown that, at embryonic day 
10-11 in the rat, there is co,  expression of MHCot and MHC/3 
throughout the heart (De Groot et al., 1989). Embryonic day 
10 in the rat corresponds to 8 d p.c.  in the mouse (Rugh, 
1990). Three of the four cardiac myosin transcripts we stud- 
ied, MHC/5,  MLCIA, and MLC1V,  are coexpressed in de- 
veloping skeletal muscle. However, these transcripts are de- 
tected in  cardiac muscle well before they are detected in 
developing somites (Fig. 1, b, d, and e; Lyons et al., 1990b). 
The first major change detected in the pattern of myosin 
transcript distribution in the developing heart occurs around 
9  d  p.c. At this stage, a  distinct atrium and ventricle have 
formed  (Rugh,  1990;  Theiler,  1989).  In  Fig.  2,  parallel 
parasagittal sections of a 9.5-d p.c. embryo with 21-24 so- 
mites demonstrate that MLC1V mRNAs (Fig. 2 b) are de- 
tected in all myocardial cells, whereas MHC/~ (Fig. 2 c) is 
largely restricted to cells in the ventricle and the outflow 
tract or ventriculoarterial portion (Pexeider et al.,  1989). 
Only a few atrial cells continue to express MHC~/(Fig. 2 c). 
MHCot transcripts (Fig.  2  d) are present at high levels in 
both the atrium and ventricle, but are decreasing in the ven- 
triculoarterial portion. MLCIA mRNAs are expressed in all 
myocardial cells at this stage (data not shown). 
At 9 d p.c., trabeculations are first seen in the ventricles 
(Sissman, 1970), and they are clearly visible in ventricles of 
a  10-d p.c. mouse embryo with 28 somites (Fig. 3). In the 
Lyons et al. Myosin Gene Expression in Mouse Cardiac Muscle  2431 Figure 7. Between 17.5 d p.c. and 7 d after birth, atrial and ventricular cells switch to the adult pattern of myosin gene expression. Dark-field 
micrographs of parallel sections of a 7-d mouse heart hybridized with the probes for (a) MHC/~, (b) MHCc~, (c) MLC1A, and (d) MLCiV. 
RC, red blood cells.  Bar,  950 #m. 
Table I. Expression of  Actin and Myosin Genes in Developing Mouse Cardiac Muscle 
Days p.c.  8.0  9.5  10.5  11.5  12.5  14.5  15.5  17.5  0.0  7.0 p.p. 
Ven~c~mu~le 
¢-Cardiacactin  +++  +++  +++  +++  +++  +++  +++  +++  +++  +++ 
MLC1A  +++  +++  +++  +++  +++  +++  ++  +  -  - 
MLC1V  +++  +++  +++  +++  +++  +++  +++  +7+  +++  +++ 
MHC~  +++  +++  ++  ++  ++  +  +  ++  ++  +++ 
MHC#  +++  +++  +++  +++  +++  +++  +++  +++  ++  - 
A~  mu~le 
~-C~ac  actm  +++  +++  +++  +++  +++  +++  +++  +++  +++  +++ 
MLC1A  +++  +++  +++  +++  +++  +++  +++  +++  +++  +++ 
MLC1V  +++  +++  +++  ++  +  +  +  +/-  -  - 
MHC~  +++  +++  +++  +++  +++  +++  +++  +++  +++  +++ 
MHC~  +  + +  +  ........ 
Sample #  4  3  7  5  7  5  7  5  4  3 
The Journal of Cell Biology, Volume  11 I, 1990  2432 developing heart, the growth rate of the trabeculated regions 
is thought to be greater than the nontrabeculated portions of 
heart, because in the adult, the portion of the ventricular wall 
that is trabeculated accounts for >90% of the total ventricu- 
lar mass (DeHaan and O'Rahilly, 1978).  In the trabeculated 
ventricle, the levels of MHCot mRNAs decrease gradually 
beginning at 10 d pc. (Fig. 3 c). 
Between 10 and 12 d p.c., another difference in the spatial 
pattern of myosin gene expression in the embryonic heart is 
detected  in  the  developing  sinuatrial  transition  (Fig.  3). 
Transcripts for the atrial isoforms: MLC1A (Fig. 3, a, b, and 
f) and MHCa (Fig. 3 c), but not MLC1V (Fig. 3 e), even 
though it is coexpressed in atrial cells at this stage, are de- 
tected in the sinuatrial transition. MHC/3 is detected at a low 
level in one portion of  the sinuatrial transition (Fig. 3 d, right 
arrowhead). This result agrees in part with the observations 
of De Groot et al. (1989), who noted that MHCot and MHC/3 
proteins are coexpressed in the developing sinus node in rat 
embryos. In the sinuatrial transition, there is a distinct ring 
or column of cells (Anderson et al.,  1978)  that forms the 
primordium of the sinus node. Fig. 3 fis a parallel section, 
hybridized with the MLC1A probe, ,o50/~m from the section 
in Fig. 3 e, showing the continuity of this ring of cells in the 
sinuatrial transition. 
As development proceeds,  the level of MHCot mRNAs 
decreases in the ventricle (Fig. 4, b and c) and MLC1V tran- 
script levels decrease in the atrium (Fig. 4 a). Fig. 4 contains 
two parasagittal sections through the atrioventricular junc- 
tion  and  ventriculoarterial  component  of an  ll.5-d  p.c. 
mouse embryo. The endocardial cushions, outflow ridges, 
and a portion of the developing interventricular septmn can 
be seen clearly in the phase-contrast micrograph (Fig. 4 b). 
The boundary for the expression of the atrial- and ventricu- 
lar-specific transcripts is the atrioventricular transition (Fig. 
4, arrowheads). The atrioventricular conduction system de- 
velops both in this transition and in a portion of the interven- 
tricular septum (Viragh and Challice, 1982). 
The next major change in the spatial distribution of cardiac 
myosin transcripts in the developing fetal heart is shown in 
Fig.  5.  At 15.5 d p.c.,  MLCIA transcripts (Fig.  5 a) and 
MHCt~ transcripts (Fig. 5 d) begin to disappear from the 
ventricle in a gradient of expression that runs from very low 
levels of expression in the ventricular wall to high levels of 
expression in the papillary muscles and interventricular sep- 
turn. By 16.5 d p.c., MLC1A transcripts (Fig. 5 e) are only 
detected in the central portion of the ventricle, and MHCot 
(Fig. 5 h) transcripts have fallen to a very low level in the 
ventricle. Both MLC1A and MHCot mRNAs continue to be 
expressed at high levels in the atria (Fig. 5, a  and e and d 
and h),  and both MLC1V mRNAs (Fig.  5,  b  and f)  and 
MHC/3 mRNAs (Fig. 5, c and g) are expressed at high levels 
in the ventricles. 
In  addition to  their  expression  within the  heart  itself, 
MLC1A and MHCot transcripts are expressed outside of the 
heart along the pulmonary and caval vessels. Fig. 6 a  is a 
phase-contrast micrograph of a  15.5-d p.o. mouse showing 
the inferior vena cava which runs from the liver to the right 
atrium.  Under dark-field illumination (Fig. 6 b),  MLC1A 
transcripts can be seen over portions of the inferior vena cava 
(arrows) near the liver and close to the atrium. At 17.5 d p.o. 
(Fig. 6 c), and at birth (Fig. 6 d), MLC1A transcripts are de- 
tected around pulmonary vessels at some distance from the 
atrium.  MHCo~ transcripts  (Fig.  6  e)  are  also  expressed 
around  these  vessels.  These  results  are  consistent  with 
reports of myocardial extensions or sleeves over pulmonary 
and caval veins in rodents (Kramer and Marks, 1965; Nathan 
and Gloobe,  1970).  The hybridization of the MHCot and 
MLCIA probes to the pulmonary and caval vessels is not due 
to crosshybridization with smooth muscle myosin  transcripts 
since no hybridization was detected to the smooth muscle in 
other blood vessels, such as the aorta, or in the gut (data not 
shown). 
After decreasing to their lowest level in the fetal ventricle 
(Fig. 5 h) at 16.5 d p.o., MHCo~ transcripts begin to increase 
rapidly. At birth, MHCot transcripts (Fig. 6 e) are present 
at higher levels than MHC/3 transcripts  (Fig.  6 f).  This 
switch continues until MHCo~ transcripts (Fig.  7  b)  have 
replaced MHC/~ transcripts (Fig,.,7 a) in the heart 7 d after 
birth.  This  result  is  consistent with  the:~gbservation  of 
Lompr~ et al. (1981), who detected only  MHCot protein in 
7-d postnatal mouse ventricles. Also at this stage, MLCIA 
transcripts (Fig. 7 c) are completely restricted to the atrium 
and only MLC1V transcripts (Fig. 7 d) are detectable in the 
ventricle. 
Table  I  summarizes the results for in situ hybridization 
with each of the myosin probes used and lists the number of 
embryos, fetuses, or postnatal hearts examined at each stage. 
We did not detect any skeletal muscle-specific MHC or 
MLC at any stage in the developing heart (Lyons et al., 
1990b). We also were unable to detect any MHC embryonic, 
which has been reported to be expressed in conductive tissue 
in rodent hearts (Gorza et al., 1988) around the time of birth 
(data not shown). 
Discussion 
We have described the temporal and spatial pattern of ex- 
pression of four cardiac myosin genes in embryonic and fetal 
mouse cardiac muscle. Although three of the four myosin 
gene transcripts we studied are also expressed in skeletal 
muscle,  these  genes,  encoding  MHC/~,  MLC1A,  and 
MLCIV, are regulated differently in the two types of striated 
muscle (see Lyons et al., 1990b). With the exception of some 
head muscles, which coexpress developmental isoforms at 
all stages (Weiczoreck et al., 1985; Soussi-Yanicostas et al., 
1990), myosin gene transcripts and proteins are expressed in 
a distinct sequence (Whalen et al., 1981; Lyons et al., 1983; 
Lyons et al., 1990a, b) during skeletal muscle development 
rather than being upregulated together initially and subse- 
quently modulated during development. 
Our results suggest that, in cardiac muscle, myosin genes 
are all expressed at high levels as soon as the cardiac tube 
forms, and that the expression of each gene is modulated in 
a different cell-specific manner during development. At 8 d 
p.c., in the tubular heart, before distinct atrial and ventricu- 
lar chambers form, each of the myosin gene transcripts we 
studied are detected throughout the myocardium. This is 
consistent with the observation that the first myocardial con- 
tractions occur at 8 d p.c.  in the mouse (Rugh, 1990;  Siss- 
man, 1970),  suggesting that all of the myosin genes are ex- 
pressed  coordinately.  In  a  similar  fashion,  cardiac  and 
skeletal  o~-actin genes  are  probably  coactivated early  in 
cardiac development (Sassoon et al., 1988), although skele- 
tal c~-actin mRNAs are always detected at a low level in the 
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the differentiation of cardiac myocytes from DMSO-treated 
embryonal carcinoma cells in vitro support our findings. 
These authors found that MHCt~,  MHC/3,  MLC2A,  and 
MLC1V proteins were coexpressed in mononucleated myo- 
cytes, and they suggest that these cells are analogous to cells 
of the early embryonic myocardium. 
Results of antibody studies of MHCs in the embryonic 
chick heart (Zhang et al., 1986; Sweeney et al., 1987) have 
shown that the ventricular MHC protein is expressed *1 d 
before the atrial MHC protein is detected. We were not able 
to detect any differences in timing or localization of expres- 
sion of the contractile protein genes we studied in the em- 
bryonic tubular heart of  the mouse. In a mouse embryo with- 
out somites, at a stage slightly earlier than that shown in Fig. 
1, we observed the same pattern of coexpression of the myo- 
sin isoforms (data not shown). 
As the cardiac tube loops and rotates upon itself to form 
the distinct atrial and ventricular chambers,  MHC/~ tran- 
script levels decrease rapidly in the atrium, but continue to 
be expressed at high levels in the ventricle. MHC~ has a 
lower myosin ATPase than MHCc~ (Hoh et al.,  1978),  and 
cardiac muscle cells expressing MHC/~ have a lower velocity 
of shortening (Schwartz et al.,  1981). These observations 
suggest that the higher levels of expression of MHC/~ tran- 
scripts in the ventricle than in the atrium may correspond to 
the differences in hemodynamic load in the different cham- 
bers of the embryonic heart. This hypothesis is supported by 
the observation that, after birth, cardiac hypertrophy due to 
hemodynamic overload is accompanied by a reexpression of 
MHC/~ transcripts in the rodent ventricle and a decrease in 
MHCa transcripts (e.g., Izumo et al.,  1987).  The changes 
in the pattern of expression of the MHC genes in the em- 
bryonic atria and ventricles may also be  correlated with 
changes in the expression of  other genes such as those encod- 
ing membrane proteins or cytoplasmic enzymes associated 
with contraction (Ingwall et al.,  1985). 
In the embryonic chick heart, MHC protein isoform ex- 
pression is correlated with local differences in the contrac- 
tion pattern of the heart (de Jong et al., 1987). There is coex- 
pression of MHCot and MHC/$  in parts of the heart with 
peristaltic contractions, but a single isoform of MHC protein 
is expressed in synchronously contracting parts of the heart 
(de Jong et al., 1987).  The switch from peristaltic contrac- 
tion to synchronous contraction in the chick ventricle coin- 
cides with the appearance of  trabeculations in the ventricular 
myocardium and with a switch from coexpression of MHC 
proteins towards expression of MHC/~ alone (de Jong et al., 
1987). 
The pattern of MLC gene expression in the developing 
mouse heart is not coordinated with that of the MHC genes. 
MHC# mRNAs are restricted to ventricular cells, except for 
some cells of the sinuatrial transition, by 10.5 d p.c., but 
MLC1V mRNAs are detected in atrial cells at a high level 
until 11.5 d p.c., and at a low level until 15.5 d p.c. This result 
does not agree with that of Rovner et al. (1990),  who noted 
that MLC1A is the exclusive MLC1 mRNA expressed in the 
rat atrium throughout development. MLC1A transcripts con- 
tinue to be expressed at a high level in ventricular cells as 
the level of MHC, transcripts drops off gradually in the em- 
bryonic mouse ventricle. When MHCt~ transcript levels in- 
crease in ventricular cells after 16.5 d p.c., MLC1A tran- 
script levels do not increase, but continue to be restricted to 
the atrium. Since MLC1A transcripts are expressed in ventri- 
cles at stages where MHC/3 is the predominant MHC iso- 
form,  and MLC1V is  expressed in atria at  stages where 
MHCct is the only MHC isoform, these MLCs must be able 
to freely associate with either MHC isoform. Whether this 
association of atrial and ventricular myosin isoforms plays a 
role in regulating contractility in the heart during develop- 
ment is not clear. There are conflicting reports on the effect 
of different MLC combinations with MHC on alterations in 
myosin ATPase and shortening velocity, which are known to 
be  correlated  (Barany,  1967).  Wagner and Stone  (1983) 
found that myosin alkali light chain exchange did not in- 
crease the ATPase activity of MHC S1  fragments in vitro. 
However, Sweeney et al. (1988) reported differences in short- 
erring velocities correlated with myosin alkali light chain ra- 
tios in isolated skeletal muscle fibers. 
The spatial pattern of decrease in the levels  of MLC1A 
transcripts in fetal ventricles is striking. Beginning at •15  d 
p.c.,  MLC1A transcripts begin to disappear in a  gradient 
running from the epicardium toward the endocardium. A 
similar gradient of expression has been observed for the dis- 
appearance of MHC/~ protein in the postnatal developing rat 
heart (Deschene et al., 1987). These authors also found that 
MHC/3 protein reappears later in the rat heart in a gradient 
of expression in the opposite direction to that in which it dis- 
appeared,  i.e.,  the  endocardium toward the  epicardium. 
Reexpression of MHC~ protein does not occur in the mature 
mouse ventricle (Lompr6 et al.,  1981). Hemodynamic fac- 
tors are known to influence MHC and MLC expression in 
the adult heart (Swynghedauw, 1986),  and have been impli- 
cated in the morphogenesis of the chick heart (Clark, 1984). 
It remains to be established whether developmental changes 
in the distribution of MHC and MLC isoforms are regulated 
by such factors as intracardial flow patterns, pressure gra- 
dients in various chambers, and transmural gradients of wall 
stress. 
It has been clearly demonstrated that some myosin genes 
are regulated differently in response to cardiac hypertrophy 
due to hemodynamic overload. In adult rat hearts, which 
normally have very low levels of MHC/~ transcripts, MHC/~ 
mRNAs accumulate in the ventricles within 2 d of the onset 
of cardiac hypertrophy induced by pressure overload (Izumo 
et al., 1987; Schiaftino et al., 1989).  As MHC/3 expression 
increases with hypertrophy, MHCot expression decreases. 
The response to cardiac hypertrophy can vary between spe- 
cies. For example, MLC1V was shown to be induced in over- 
loaded atria in human subjects (Cummins,  1982;  Kuraba- 
yashi et al.,  1988),  but not in rats (McNally et al.,  1989). 
Some myosin genes, such as MLC1A, appear to be less re- 
sponsive to cardiac hypertrophy (Rovner et al., 1990).  The 
mechanisms by which myosin genes are regulated in response 
to hypertrophy are not known. 
The pattern of expression of the MHCa gene in the de- 
veloping mouse heart is unique in that, after being gradually 
restricted to atrial cells in the embryo, MHCa transcripts are 
reexpressed in ventricular cells from 2 d before birth, and 
replace MHC/3 transcripts by 7 d after birth. Lompr¢ et al. 
(1984)  have suggested that there may be two distinct, de- 
velopmentally regulated MHCa gene transcripts that differ 
only at their 3' ends. Our results do not support, but do not 
rule out, this hypothesis since our MHCa probe is com- 
plementary to the 3' UTR of the MHCa gene transcript. 
The reexpression of MHCot transcripts may be due to se- 
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thyroid hormone (T3) has been shown to upregulate MHCot 
expression  and to  downregulate  MHCB  (Lompr~  et  al., 
1984). Even though thyroid hormone levels are low at birth 
(Gambke et al., 1983) in rodents, there may be sufficient T3 
supplied by the maternal circulation to begin the switch from 
MHCfl to MHCot gene expression in the heart. Chizzonite 
and Zak (1984) showed that in rats made hypothyroid from 
15 d p.c., the amount of MHCo~ protein in the ventricle  at 
19 d p.c. is reduced compared to euthyroid controls, and that 
by 7 d after birth,  the hypothyroid ventricle  contains only 
MHCfl.  Thus,  hypothyroidism  apparently  reverses  the 
switch in the two isoforms, which normally occurs during 
development. Other factors than T3, such as dietary carbo- 
hydrate,  glucocorticoids  (Sheer  and  Morldn,  1984),  and 
catecholamines,  particularly  norepinephrine  (Bishopric  et 
al.,  1989), may also be involved in this transition. 
With  the  exception  of thyroid  hormone/receptor  com- 
plexes, which have been shown to interact directly with the 
MHCcx gene promoter (Izumo and Mahdavi,  1988; Glass et 
al.,  1989), differentiation and transcriptional factors impli- 
cated in the initiation of the myogenic program and in myosin 
gene regulation in the heart are still mostly unidentified.  Of 
the  factors  that  have  been  identified  in  skeletal  muscle, 
MyoD1 (Davis et al., 1987), myogenin (Wright et al., 1989), 
myf-5 (Braun et al.,  1989), and myf-6 (Braun et al.,  1990), 
none are expressed in cardiac muscle (Sassoon et al., 1989; 
Lyons et al., 1990a). Thus, the cardiac myosin genes that are 
coexpresscd in skeletal muscle must be regulated by different 
mechanisms in cardiac and skeletal  muscle. 
Our results support the hypothesis that the mechanisms of 
myosin gene regulation in these two types of striated muscle 
must be quite different, since the developmental patterns of 
expression of myosin genes in  skeletal  muscle are unlike 
those detected  in cardiac muscle. After an initial high level 
of coexpression in the myocardium of the embryonic cardiac 
tube, the expression of each myosin gene is modulated in a 
different cell-specific and stage-specific manner in develop- 
ing atrial and ventricular myocytes. 
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